Status:
COMPLETED
Effect of Implant Position on Magnetic Resonance Image Distortion
Lead Sponsor:
Manchester University NHS Foundation Trust
Conditions:
Neurofibromatosis Type 2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients with Neurofibromatosis type 2 (NF2) almost always develop acoustic neuromas in both ears. As a result of the tumours themselves or the treatment of the tumours, many patients become profoundl...
Detailed Description
Auditory brainstem implants (ABI) are placed against the auditory centres in the brainstem if it is not possible to implant the cochlea or if the cochlear nerve, which conveys neural signals from the ...
Eligibility Criteria
Inclusion
- \- Any patient over the age of 18 with NF2 who has an auditory implant (cochlear or auditory brainstem implant) in situ and requires MRI scanning.
Exclusion
- Children under the age of 18 years Claustrophobia Bilateral implants
- Contraindications and relative contraindications for MRI (as per the Radiology Department MRI protocol) including:
- Pacemaker Certain metallic heart valves Ferromagnetic implanted materials and foreign bodies
Key Trial Info
Start Date :
February 3 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2015
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT02246231
Start Date
February 3 2014
End Date
January 31 2015
Last Update
March 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Central Manchester University Hospitals NHS Foundation Trust
Manchester, Manchester (Manchester Borough), United Kingdom, M13 9WL